Skip to content

The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment

The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04079946
Enrollment
40
Registered
2019-09-06
Start date
2019-10-01
Completion date
2021-06-01
Last updated
2019-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Colon

Keywords

cancer colon

Brief summary

Cancer Colon is one of the major public health problems worldwide. Complete eradication of the tumor with no recurrence or residual masses is a challenge which faces all the surgeons and medical staff all over the world. A lot of techniques were used to ensure 100 % eradication of the tumor and to cure the patients from cancer. Total Mesocolic Excision with Central Vessel Ligation is one of the recent techniques used for colon cancer surgeries. Here in the research the investigators answer the question of how this technique is superior and more beneficial in complete eradication of the tumor than the conventional surgery for colon cancer

Interventions

PROCEDURETotal Mesocolic Excision with Central Vessel Ligation

sharp dissection of the anatomical layers and the dissection of the visceral plane from the parietal one . In addition a central division of the feeding arteries at their origins is performed at the level of superior mesenteric artery for tumors of the right colon and at the level of inferior mesenteric artery or the aorta for tumors of the left colon .this allows for removal of the maximum number of lymph nodes possible.

PROCEDUREconventional surgery of cancer colon

removal of the tumor with no ligation of the vessel centrally or removal of the whole mesocolon

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Adult male and female Age of or above 18 years. * Tumor localization at the caecum, ascending colon, transverse colon, descending colon, sigmoid colon or rectosigmoid on preoperative endoscopy and radiographic imaging \[barium enema or computed tomography (CT)\] * No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease * Written informed consent

Exclusion criteria

* • Contraindications to major surgery and American Society of Anaesthesiologists (ASA) Physical Status scoring 4 which means extreme systemic disorders which have already become an eminent threat to life regardless of the type of treatment. * Infectious disease requiring treatment. * Pregnant women * Use of systemic steroids. * Severe pulmonary emphysema or pulmonary fibrosis

Design outcomes

Primary

MeasureTime frameDescription
Lymph nodes harvestTwo yearsNumber of retrieved lymph nodes can be extracted by this technique

Contacts

Primary ContactAmr E. Hassan, resident Doctor
amrelfayed@gmail.com01004664295

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026